Pellerano, C. published the artcileTridentate N-N-N chelating systems as potential antitumoral agents, Computed Properties of 2215-33-0, the publication is Farmaco, Edizione Scientifica (1985), 40(9), 645-54, database is CAplus and MEDLINE.
Tridentate chelating agents were prepared as derivatives of 2-quinolylhydrazine (I; R = H, Me; R1 = H, Me, MeO; R2 = H, Me; R3 = H, Me), 2-pyridylhydrazine (II; R2 = H, Me, Ph; R3 = H, Me), and 2-benzothiazolylhydrazine (III; R2 = H, Me, Ph; R3 = H, Me) and tested for antitumor activity in mice bearing lymphocytic leukemia P388. Several of the compounds, including 1-(4‘-methyl-2‘-quinolyl)-3-(2‘-pyridyl)-1,2-diaza-2-propene [71508-71-9], showed some activity against lymphocytic leukemia P388 in mice; the latter compound, however, was inactive when tested against other tumors.
Farmaco, Edizione Scientifica published new progress about 2215-33-0. 2215-33-0 belongs to pyridine-derivatives, auxiliary class Pyridine,Amine, name is 2-((2-(Pyridin-2-yl)hydrazono)methyl)pyridine, and the molecular formula is C11H10N4, Computed Properties of 2215-33-0.
Referemce:
https://en.wikipedia.org/wiki/Pyridine,
Pyridine | C5H5N – PubChem